3-tyr-octreotide has been researched along with 3-iodobenzylguanidine in 2 studies
| Studies (3-tyr-octreotide) | Trials (3-tyr-octreotide) | Recent Studies (post-2010) (3-tyr-octreotide) | Studies (3-iodobenzylguanidine) | Trials (3-iodobenzylguanidine) | Recent Studies (post-2010) (3-iodobenzylguanidine) |
|---|---|---|---|---|---|
| 95 | 2 | 4 | 3,563 | 260 | 1,054 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Besser, GM; Bomanji, J; Britton, KE; Ellison, D; Grossman, A; Mather, S; Moyes, J | 1 |
| Carnaille, B; Huglo, D; Marchandise, X; Nocaudie-Calzada, M; Proye, C | 1 |
2 other study(ies) available for 3-tyr-octreotide and 3-iodobenzylguanidine
| Article | Year |
|---|---|
A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
Topics: 3-Iodobenzylguanidine; Aged; Carcinoid Tumor; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Octreotide; Radionuclide Imaging | 1992 |
Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Contrast Media; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Octreotide; Pentetic Acid; Prospective Studies; Radionuclide Imaging; Sensitivity and Specificity | 1996 |